Skip to Content
Pan American Parkinson’s Disease and Movement Disorders Congress

Evaluations

All evaluations must be completed by June 30, 2026.
 

Overall Evaluation

Submit feedback

 

Session Evaluations

Friday, February 13

Plenary Session 1101  Hot Topics in Movement Disorders
Plenary Session 1102 Novel Genetic Therapies for Movement Disorders
Parallel Session 1201 How Neuroimaging is Rapidly Transforming the Diagnosis and Treatment of Parkinson's Disease
Parallel Session 1203 Huntington's Disease and the Secondary Choreas
Parallel Session 1202 Update on Hyperkinetic Movement Disorders: Clinical Pearls and Evolving Therapies
Video Session 1304 Eye Movements and Ocular Disorders for Diagnosis of Movement Disorders
Skills Workshop 1305 Rare Treatable Movement Disorders
Skills Workshop 1306 Treatment Strategies for Functional Movement Disorders: Beyond Cognitive-Behavioral Therapy

 

Saturday, February 14

Plenary Session 2103 Ataxia Therapies: What Works, What's New, and What's Next?
Plenary Session 2104 Novel Clinical Trials Movement Disorders
Parallel Session 2201 From Mechanisms to Management: Integrating Digital Tools in the Assessment and Treatment of Gait Disorders in Parkinson’s Disease
Parallel Session 2202 Genetic Testing in Movement Disorders: A Practical Guide for Optimizing Test Selection and Report Interpretation
Parallel Session 2203 Integrated Care in Movement Disorders: Multidisciplinary Models for Better Outcomes
Video Session 2305 Deep Brain Stimulation and Focused Ultrasound
Skills Workshop 2306 Lessons from My Patients
Video Session 2304 Pediatric Movement Disorders

 

Sunday, February 15

Plenary Session 3105 Artificial Intelligence (AI) in Movement Disorders
Plenary Session 3106 Controversies in Movement Disorders